Skip to main content

Table 1 Distribution of participants (all with diabetes) at baseline visit in 2005–2007, and distribution and cause of not participating at follow-up visit in 2015

From: Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case–control study

 

Groups with diabetes and Charcot foot

Groups with diabetes but without Charcot foot

Distribution of participants at baseline visit 2005–2007a

Acute CF (n = 17)

Chronic CF (n = 7)

1. toe amputee (n = 5)

Neuropathy (n = 9)

Without neuropathy (n = 11)

 Passed away before follow-up

3 (17%)

3 (43%)

3 (60%)

3 (33%)

0 (0%)

 How many were amputated before death

2

2

1

0

N/A

 Unable to reach/moved abroad

1

1

1

0

1

 Declined participation

2

0

1

2

2

 Excluded due to amputation

1

2

0

1

0

 Participants available for follow-up measurements

10

1

0

3

8

Distribution of participants at follow-up visit 2015

Previous Charcot foot (DM + CF)

n = 11

No previous Charcot foot (DM − CF)

n = 11

  1. aPlease see [11, 18] for details